Log In
BCIQ
Print this Print this
 

EscharEx

  Manage Alerts
Collapse Summary General Information
Company MediWound Ltd.
DescriptionEnzymatic debriding agent
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPhase II
Standard IndicationWounds
Indication DetailsDebridement of dead or damaged tissue in chronic and other hard-to-heal wounds; Treat chronic and other hard-to-heal wounds
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today